DATASET RE-READ 2026-11-2042 PROGRAMSNEXLIFE PRICES READ 2026-11-20EVERY FIGURE CARRIES ITS READ DATE
TopGLP1Providers.comverified price index
DATED PRICES

IVIM Health tirzepatide: November 2026 price and position

As of November 20, 2026, IVIM Health charges $192 a month for compounded tirzepatide month to month, all-in, according to its own page. That is a starting-dose figure; the price rises with the dose, so ask for the maintenance-dose price in writing.

Released · Last reviewed · how we verify

Check IVIM Health’s tirzepatide price ↗

IVIM Health tirzepatide prices, read November 20, 2026

IVIM Health compounded tirzepatide, all-in figures from its own page read November 20, 2026 (medication plus any required recurring fee, before tax)
MeasureAmountBasis
Month to month, all-infrom $192per month, starting-dose price
Lowest printed rate$192$117 + $75 program fee

FDA warning letters

FDA’s warning-letter index lists warning letter 721816 (dated February 20, 2026, subject “False & Misleading Claims/Misbranded (Telehealth)”) to IVIM Health; no close-out letter is listed. A warning letter is FDA’s formal notice of alleged violations, not a recall, ban or court finding.

Limitations and what to check before you enroll

Compounded tirzepatide is not FDA-approved and is not the same product as Zepbound; it is made for an individual patient by a state-licensed pharmacy. Ask IVIM Health for the all-in price at the maintenance dose, what is charged today and how often, and which pharmacy fills the prescription. A clinician decides whether any GLP-1 is right for you.

Frequently asked

How much does IVIM Health charge for tirzepatide?

As of November 20, 2026, IVIM Health charges $192 a month for compounded tirzepatide month to month, all-in, according to its own page. That is a starting-dose figure; the price rises with the dose, so ask for the maintenance-dose price in writing.

Is IVIM Health’s tirzepatide FDA-approved?

No. Compounded tirzepatide from any telehealth program, IVIM Health included, is not FDA-approved and is not the same product as Zepbound or Mounjaro. It is made for an individual patient by a state-licensed compounding pharmacy. Brand Zepbound is the FDA-approved version.

Where do these IVIM Health figures come from?

From IVIM Health’s own page (first-party read, November 20, 2026), converted to an all-in month-to-month figure (medication plus any required recurring fee, before tax). The source link and read date are listed below, and the same figures are in the open dataset.

IVIM Health reviewIVIM Health semaglutideTirzepatide price tableCheapest tirzepatide providersRankings

Sources

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.